Leerink Partners Raises Eli Lilly Price Target to $1,508
Leerink Partners raised its target price for Eli Lilly to $1,508 from $1,316.
Story updates
02:53:00 AM UTC
SquawkNews
ELI LILLY: JP MORGAN RAISES TARGET PRICE TO $1650 FROM $1500
02:59:08 AM UTC
SquawkNews
ELI LILLY: RBC RAISES TARGET PRICE TO $1600 FROM $1500